(Q64043938)

English

Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy

clinical trial

Statements

A Randomized, Double-Masked, Fellow-Eye Comparison Of The Safety And Efficacy Of 0.2 And 0.5 µg/Day Fluocinolone Acetonide Intravitreal Insert To Sham Injection In Subjects With Bilateral Geographic Atrophy Due To AMD (English)
0 references
0 references
0 references
December 2008
0 references
October 2013
0 references
17
0 references
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit